N-Nitroso Fedratinib Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Fedratinib is used to treat adults with certain types of myelofibrosis (MF; a cancer of the bone marrow in which the bone marrow is replaced by scar tissue and causes decreased blood cell production). Fedratinib is in a class of medications called kinase inhibitors.N-Nitroso Fedratinib Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Fedratinib Impurity 1 CAS NO:NA Chemically represented as N-(Tert-butyl)-3-((5-methyl-2-(nitroso(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl) (nitroso) amino) benzenesulfonamide .Synchemia is the leading manufacturing and exporter of N-Nitroso Fedratinib Impurity 1.We supply N-Nitroso Fedratinib Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141031 |
| CAS No | NA |
| Mol.F. | C10H15N7OS |
| Mol.Wt. | 281.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141032 |
| CAS No | NA |
| Mol.F. | C22H27N5O7 |
| Mol.Wt. | 473.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141033 |
| CAS No | NA |
| Mol.F. | C22H24N8O10 |
| Mol.Wt. | 560.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141034 |
| CAS No | NA |
| Mol.F. | C22H25N7O9 |
| Mol.Wt. | 531.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141035 |
| CAS No | NA |
| Mol.F. | C22H26N6O8 |
| Mol.Wt. | 502.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141036 |
| CAS No | NA |
| Mol.F. | C22H27N5O7 |
| Mol.Wt. | 473.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141037 |
| CAS No | NA |
| Mol.F. | C22H26N6O8 |
| Mol.Wt. | 502.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141038 |
| CAS No | NA |
| Mol.F. | C7H16ClN4O6P |
| Mol.Wt. | 318.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141039 |
| CAS No | NA |
| Mol.F. | C7H17ClN3O5P : H2O |
| Mol.Wt. | 289.7 : 18.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141041 |
| CAS No | NA |
| Mol.F. | C4H9ClN2O2 |
| Mol.Wt. | 152.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141042 |
| CAS No | NA |
| Mol.F. | C7H17ClN3O5P |
| Mol.Wt. | 289.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141043 |
| CAS No | NA |
| Mol.F. | C7H14Cl2N3O3P : H2O |
| Mol.Wt. | 290.1 : 18.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141040 |
| CAS No | NA |
| Mol.F. | C7H15ClN3O4P |
| Mol.Wt. | 271.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141044 |
| CAS No | NA |
| Mol.F. | C28H48N14O6 |
| Mol.Wt. | 676.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141045 |
| CAS No | NA |
| Mol.F. | C28H53N9O |
| Mol.Wt. | 531.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141046 |
| CAS No | NA |
| Mol.F. | C28H53N9O : (C2H4O2) |
| Mol.Wt. | 531.8 : (60.1) |
| INV STATUS | CUSTOM SYNTHESIS |